Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Cronos Group by Quarter
Cronos Group — Israel Medical Cannabis Net Revenue ($K)
Altria Cronos Group: 15,018 in Q2 2026, up 60.2% from a year earlier. That is the highest of the 14 quarters on record here.
Latest, Q2 2026
15,018
Period ended Jun 30, 2026
Change on a year earlier
+60.2%
9,376 in Q2 2025
History
14 quarters
Since Q1 2023
Sources
9
Documents cited below
Where the Q2 2026 figure comes from
“|| Israel | 15,018 | 9,376”
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Cronos Group, quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/cron-rev-israel-k
See every metric in the Altria KPI table. Data updated Nov 2, 2026.